Treatment-free remission (TER) following nilotinib (NIL) in patients (pis) with chronic myeloid leukemia in chronic phase (CML-CP): ENESTfreedom, ENESTop, ENESTgoal, and ENESTpath Meeting Abstract
| Authors: | Mahon, F. X.; Baccarani, M.; Mauro, M. J.; Hughes, T. P.; Sagilo, G.; Savona, M.; Szczudlo, T. K.; Menssen, H. D.; Keir, C. H.; Walasok, C.; Hochhaus, A. |
| Abstract Title: | Treatment-free remission (TER) following nilotinib (NIL) in patients (pis) with chronic myeloid leukemia in chronic phase (CML-CP): ENESTfreedom, ENESTop, ENESTgoal, and ENESTpath |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202188 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.tps7124 |
| Notes: | Meeting Abstract: TPS7124 -- Source: Wos |
